The U.S. Food and Drug Administration (FDA) and Health Canada have approved the use of the Maria Research Reactor in Poland as a site to irradiate highly-enriched uranium targets for molybdenum-99 (Mo-99) production, according to Covidien.
William Denman, MD, has been appointed chief medical officer (CMO) at GE Healthcare.
Babcock & Wilcox Technical Services Group (B&W TSG) has been awarded $9 million from the National Nuclear Security Administration for the development of reactor technology for medical isotope production using low enriched uranium.
There will be no Covidien generator production from March 21-25 in the Americas and from March 20-23 in Europe, the Middle East and Africa due to lack of molybdenum-99 supply, as all five major medical isotope reactors in Europe, Canada and South Africa will be off-line during this period.
After years of research regarding gadolinium-based contrast agents used during MRI being linked to the skin disease nephrogenic systemic fibrosis (NSF), the FDA has found the greatest risk in GE Healthcare’s Omniscan, Bayer HealthCare's Magnevist and Covidien’s Optimark.
Covidien has reported several internal changes that will affect its financial reporting, including the combination of its pharmaceutical products and imaging solutions segments into a single operating segment called pharmaceuticals.
Covidien has reported a decline in sales for its fiscal 2009 third quarter, which ended June 30.
The American College of Radiology, SNM and a coalition of seven other organizations are urging Congress to take steps to maintain adequate supplies of molybdenum-99 (Mo-99).
Health Canada has approved Covidien's abbreviated new drug submission for its kit for the preparation of Technetium Tc99m Sestamibi injection. Covidien's product is a generic substitute for Cardiolite, a myocardial perfusion imaging agent used for detecting coronary artery disease.
Covidien has reached a definitive agreement to acquire VNUS Medical Technologies, a developer of medical devices for minimally invasive treatment of venous reflux disease, for approximately $440 million.
|
Covidien and the Institute of Atomic Energy in Poland have agreed to augment the global supply of molybdenum-99 (Mo-99) by adding the Poland’s Maria Research Reactor to the company's supply chain.
CT is being utilized as an adjunctive tool in the evaluation of patients presenting with complicated H1N1 flu cases in hospitals, which can be positive for both the technology and medical imaging agent manufacturers, said life sciences market research group Kalorama Information.
Medical device and drug manufacturer Covidien reported a 6.7 percent increase in profits in the first quarter of 2010, which ended Dec. 25, 2009.
Covidien, a provider of healthcare products, announced Thursday a definitive agreement to sell its U.S. radiopharmacies to Triad Isotopes of Orlando, Fla. Financial terms of the transaction were not disclosed.
Global healthcare products company Covidien took charges in its fiscal 2009 fourth quarter, which ended Sept. 30, that saw profits slide 86 percent compared with the same period last year.
A federal judge has cut the potential damages Covidien's Mallinckrodt subsidiary can receive in its patent infringement case over medical injectors against two U.S. divisions of Bracco—Lake Success, N.Y.-based E-Z-EM and Acist Medical Systems of Eden Prairie, Minn.
Past studies have indicated a benefit regarding the use of an iso-osmolar contrast agent versus low-osmolar contrast media. A new meta-analysis in the July issue of JACC: Cardiovascular Interventions suggests the two types of contrast agents are equivalent in terms of the risk of acute kidney injury.
Covidien's subsidiary Mallinckrodt has recalled one lot of Sodium Chromate Cr-51 injection as a result of routine post-market testing, which found the product to be subpotent.
Canadian hospitals will see partial relief from the medical isotope shortage as the High Flux nuclear reactor in Petten, the Netherlands, boosts its production to fill some of the void caused by the recent and unexpected shutdown of the Chalk River facility in Ontario.
Covidien has reported a decline in net income for the second quarter of fiscal 2009, which ended March 27, due in part to lower than expected results in its imaging sector and tax charges related to its split from Tyco International.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.